Review Article
Preclinical Studies and Translational Applications of Intracerebral Hemorrhage
Table 3
Previous and current clinical trials.
| Agent | Name of study | Result | Trial Number | Target |
| Mannitol | | No significance | | Edema [16] |
| rFVIIa | FAST | Ongoing | NCT00127283 | Hematoma regrowth [17] |
| Fingolimod | | Phase 2 | NCT02002390 | Edema [18] |
| NXYO59 | CHANT | No significance | | Free radical [19] |
| Deferoxamine | DFO-ICH | Ongoing | NCT02175225 | Iron chelation & perihematomal edema | NCT02367248 |
| Pioglitazone | SHRINC | Phase 3 | NCT00827892 | PPARγ-agonist [20] |
| Celecoxib | ACE-ICH | Ongoing | | cyclooxygenase-2 |
| Hypertension | CHANT | Ongoing | | Hematoma regrowth & BP control [20] | INTERACT | Completed | | Hematoma regrowth & BP control [21] | ADAPT | Completed | | Hematoma regrowth & BP control [22] | ATTACH | No significance | | Hematoma regrowth & BP control [23] |
| Stem cell | | Ongoing | NCT02065778 NCT02245698 NCT01832428 NCT01714167 | Many targets [24] |
| Electroacupuncture | | Ongoing | | Many targets |
|
|